JUN 19, 2015 4:16 PM PDT

Surface Sampling Probe for Surgeons

WRITTEN BY: Ilene Schneider
An automated droplet-based surface sampling probe can help a surgeon to determine whether a patient's tissue is cancerous - while that patient is still on the operating table. Researchers from the Department of Energy's Oak Ridge National Laboratory and Brigham and Women's Hospital/Harvard Medical School say the tool cuts analysis time from 20 or 30 minutes to 10 minutes and expect to cut that number in half.
A new tool would let surgeons know if tissue is cancerous while the patient is still on the operating table.
According to an article in Analytical and Bioanalytical Chemistry that was reported in Science Daily, the mass spectrometry-based technology can be used in place of immunohistochemistry, or IHC, that searches looks for specific protein biomarkers to make a diagnosis. In the words of the article, "Although the IHC approach provides a high degree of spatial recognition, it is time consuming and limited by the quality and specificity of the antibody used to detect the protein"
(DOE/Oak Ridge National Laboratory. "New tool on horizon for surgeons treating cancer patients." ScienceDaily. ScienceDaily, 18 June 2015) (www.sciencedaily.com/releases/2015/06/150618145912.htm).

The team, led by ORNL's Vilmos Kertesz, profiled two hormones from human pituitary tissue. As Kertesz explained, "Instead of having to cut and mount tissue and wait for a trained pathologist to review the sample under a microscope, a technician might soon perform an equally conclusive test in the operating environment." The researchers based their work on patents from previously funded DOE projects and said that it advances the liquid microjunction surface sampling probe technology first patented by ORNL.

Other mass spectrometry-based techniques, including desorption electrospray ionization and rapid evaporative ionization mass spectrometry are being evaluated for classifying tumors and providing prognostic information, but they usually analyze lower molecular weight biomolecules such as metabolites, fatty acids and lipids. The droplet-based method developed at ORNL is not limited in this way. Thus, it can enhance surgical decision-making, Kertesz stated.

Kertesz and his colleagues have also used the fully automated droplet-based surface-sampling system for determining the distribution of drugs and their metabolites in rat thin tissue sections. Such analysis is based on the use of an autosampler coupled to HPLC/MS and capable of liquid-extraction based surface sampling. This system enables the analyst to work with complex sample matrices and to identify isomeric compounds not distinguishable by direct surface sampling methods alone (www.future-science.com/doi/abs/10.4155/bio.14.130).

"On the basis of the results and the relative simplicity, rapidity and specificity of our method, there is great potential for our technology to assist surgeons in the detection of cancer from tissue biopsy samples," said Kertesz, a member of ORNL's Organic and Biological Mass Spectrometry Group and lead author of the paper (http://oakridgetoday.com/2015/06/18/ornl-new-tool-on-horizon-for-surgeons-treating-cancer-patients/#more-57779).
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
MAR 29, 2020
Cancer
MAR 29, 2020
Improving ependymoma diagnostics
Have you ever heard of ependymoma? This rare form of brain cancer most commonly occurs in young children when tumors for ...
APR 14, 2020
Immunology
APR 14, 2020
Immunotherapy Shows Promise, Destroys Metastatic Brain Tumors
Lung cancer is the leading cause of death in both men and women in the U.S., with smokers bearing an elevated risk of th ...
APR 19, 2020
Cancer
APR 19, 2020
Discovery of new biomarker detects urological cancer
New hope for the detection of urological cancers has been published in a study in the Journal of Extracellular Vesicles. ...
MAY 12, 2020
Clinical & Molecular DX
MAY 12, 2020
Could Catching the Flu Be Linked to an Increased Cancer Risk?
Results from a new research study suggest that a spike in infections such as influenza could be linked to the risk of de ...
MAY 12, 2020
Drug Discovery & Development
MAY 12, 2020
Novel Drug Approved for Non-Small Cell Lung Cancer
The US Food and Drug Administration (FDA) recently approved a therapeutic for treating metastatic non-small cell lung ca ...
JUN 01, 2020
Cancer
JUN 01, 2020
A New RNA in Fine-Tuned Signal Regulation
In a healthy cell, many complex networks work to make sure everything runs as it should. Some of these networks function ...
Loading Comments...